CIK 0001108205
- Non-accelerated filer
- Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043505116
- Phone
- +1 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 4 Open-market sale Director sold 50,000 shares at $4.31 ($215,500)
- 4 Open-market sale VP, Tech Management sold 48,000 shares at $4.74 ($227,520)
- 4 Open-market sale Director sold 300,000 shares at an average $4.75 ($1,426,170)
- 4 Open-market sale CEO and Director sold 110,650 shares at an average $4.82 ($533,360)
- 4 Open-market sale VP, Tech Management sold 74,100 shares at $4.78 ($354,198)
- 4 Open-market sale COO and CFO sold 42,844 shares at $5.01 ($214,648)
- 4 Open-market sale Director sold 80,000 shares at $4.92 ($393,600)
- 4 Exercise or conversion CEO and Director acquired 60,750 shares (option exercise)
- 4 Exercise or conversion Director acquired 77,500 shares (option exercise)
- 4 Exercise or conversion Director acquired 257,500 shares (option exercise)
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 24 · 475 filings